Aquestive Therapeutics, Inc. AQST Other — Total General and Administrative Expenses

Other product segments

Similar metrics at other companies

TRUPOther Segments — General and Administrative Expense

$5.7M-10.0%

LZOther General and Administrative Expense

$31.22M-20.4%

GYREAll Other Segments — General And Administrative Expense

$6K+100%

AMCOther General and Administrative Expense

$60.9M+8.8%

MNKDAll Other Segments — General And Administrative Expense

$15.51M+37.9%

REPXOther General and Administrative Expense

$8.12M+9.2%

Questions, answered.

What is Aquestive Therapeutics, Inc.'s other — total general and administrative expenses?

Aquestive Therapeutics, Inc. (AQST) reported other — total general and administrative expenses of $3.55M in Q1 2026.

How has Aquestive Therapeutics, Inc.'s other — total general and administrative expenses changed year-over-year?

Aquestive Therapeutics, Inc.'s other — total general and administrative expenses decreased by 68.5% year-over-year, from $11.28M to $3.55M.

What is the long-term trend for Aquestive Therapeutics, Inc.'s other — total general and administrative expenses?

Over 2 years (2023 to 2025), Aquestive Therapeutics, Inc.'s other — total general and administrative expenses has grown at a 46.5% compound annual growth rate (CAGR), from $19.34M to $41.53M.

What does other — total general and administrative expenses mean?

This metric captures the overhead and operational support costs required to manage the segment's day-to-day business activities, excluding direct production or sales costs. It includes allocations for executive management, legal, human resources, and other corporate functions supporting the segment's operations. Tracking this metric is essential for evaluating the segment's operational leverage and the efficiency of its administrative infrastructure.